These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18769249)

  • 1. Intravenous immunoglobulins in the treatment of immune neuropathies.
    Kieseier BC; Meyer Zu Hörste G; Lehmann HC; Gold R; Hartung HP
    Curr Opin Neurol; 2008 Oct; 21(5):555-62. PubMed ID: 18769249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange in immune-mediated neuropathies.
    Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
    Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 4. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based treatment of chronic immune-mediated neuropathies.
    Magy L; Vallat JM
    Expert Opin Pharmacother; 2009 Aug; 10(11):1741-54. PubMed ID: 19601698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of immune neuropathies with intravenous immunoglobulins.
    Gold R; Kieseier BC
    J Neurol; 2006 Sep; 253 Suppl 5():V59-63. PubMed ID: 16998755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated neuropathies.
    Kiefer R; Kieseier BC; Hartung HP
    Adv Neurol; 2002; 88():111-31. PubMed ID: 11908221
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune diseases of the peripheral nervous system.
    Kieseier BC; Lehmann HC; Meyer Zu Hörste G
    Autoimmun Rev; 2012 Jan; 11(3):191-5. PubMed ID: 21621007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of idiopathic inflammatory neuropathies.
    Donofrio PD
    Muscle Nerve; 2003 Sep; 28(3):273-92. PubMed ID: 12929187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inflammatory and paraproteinemic neuropathies.
    Monaco S; Turri E; Zanusso G; Maistrello B
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dys-immune neuropathies.
    Nobile-Orazio E
    J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update.
    Nobile-Orazio E; Gallia F; Tuccillo F; Terenghi F
    Curr Opin Neurol; 2010 Oct; 23(5):519-23. PubMed ID: 20689427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune-mediated neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):956-8. PubMed ID: 20030259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inflammatory neuropathies.
    Hadden RD; Hughes RA
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74 Suppl 2(Suppl 2):ii9-ii14. PubMed ID: 12754323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dysimmune neuropathies with intravenous polyvalent human immunoglobulins].
    Leger JM; Hoang-Xuan K; Chennoufi A; Saidi H; Bouche P; Baumann N; Brunet P
    Presse Med; 1992 Oct; 21(32):1533. PubMed ID: 1334543
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.